The company's management pointed to a decrease in demand fro...
The company's management pointed to a decrease in demand from its pharma and biotech customers, leading to a revenue decline in its life sciences business.
Revvity Stock Tumbles 18% as Demand From Pharma and Biotech Customers Falls -- Barrons.com
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
3552Followers
0Following
8378Visitors
Follow